RCS - deepc - deepc, Announces Eur12 million Series A Round

Bertelsmann SE & Co KGaAAnnouncement

28/03/2023 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230328:nRSb4549Ua&default-theme=true

RNS Number : 4549U  deepc  28 March 2023

Digital Medicine Pioneer, Deepc, Announces €12 million Series A Round Led by
Sofinnova Partners

·      The investment will enable the company to develop new features
and expand commercialization of deepcOS®, its proprietary operating system
that powers AI integration within radiology workflows

·      Simon Turner, Partner at Sofinnova Partners, joins deepc's Board
of Directors

·      Bertelsmann Investments and Winning Mindset Ventures also
participated in the round

MUNICH, GERMANY / ACCESSWIRE / March 28, 2023 / deepc ("The Company"), a
digital medicine pioneer that gives healthcare systems the flexibility to
adopt and integrate third-party artificial intelligence (AI) technology into
existing workflows and ultimately improve patient outcomes, announced today
that it has raised a €12 million Series A round led by Sofinnova Partners, a
leading European venture capital firm in life sciences, specializing in
healthcare and sustainability. The proceeds will be used to propel the
commercialization of the deepcOS® AI operating system and further develop
streamlined services to improve the user experience for radiologists.
Bertelsmann Investments and existing investor Winning Mindset Ventures also
participated in the round.

The company's core technology, deepcOS®, is a cloud-native, vendor-neutral
platform that integrates seamlessly with existing radiology workflows. It
provides approved third-party AI vendors with an efficient way to
commercialize their solutions while offering hospitals and clinics a secure,
"one-stop shop" for their AI-assisted radiology needs.

"At deepc, we believe that AI has the power to revolutionize the way we
approach healthcare," said Dr. Franz Pfister, co-founder and CEO of deepc.
"Our AI platform, deepcOS, is a game changer for radiology, allowing for
faster, more accurate diagnoses and ultimately improving patient outcomes. We
are thrilled to welcome Sofinnova Partners and Bertelsmann Investments on
board. Their extensive networks in the healthcare ecosystem will propel deepc
forward."

The proceeds will expand deepc's geographic coverage and develop additional
features within deepcOS®. Radiology teams will benefit as new AI-assisted
options are seamlessly integrated into their workflows. At the same time, AI
software vendors will get low-friction access to a large number of potential
customers.

"Our investment in deepc underscores our conviction that Digital Medicine
holds enormous promise and that enabling technologies will be at the forefront
of the digital revolution in healthcare, precisely the focus of our Digital
Medicine investment strategy," said Simon Turner, Partner at Sofinnova
Partners. "deepcOS enables wide adoption of AI into a major part of the
patient journey. The team has demonstrated the benefit that they can provide
to healthcare professionals and patients."

 Company contact:                                             Press contact:

 Julia Moosbauer (COO, deepc)                                 Hollie Vile (Optimum Strategic Communications)

 julia.moosbauer@deepc.ai (mailto:julia.moosbauer@deepc.ai)   sofinnova@optimumcomms.com (mailto:sofinnova@optimumcomms.com)

 www.deepc.ai (https://pr.report/QkqGaejb)                    +44 (0) 20 3922 0900

About deepc

Driven by a desire to ensure precise diagnostics for all patients, deepc is on
a mission to cut through the challenges of a crowded AI market and provide
radiology teams with seamless access to an array of the best
regulator-approved AI diagnostic tools. Its growing team of more than 40
employees with 20 different nationalities working in seven cities is dedicated
to improving the AI user experience for radiologists while easing market
access for AI software vendors.

For more information, please visit: www.deepc.ai (https://pr.report/gUHlw1he)

About Sofinnova Partners

Sofinnova Partners is a leading European venture capital firm in life
sciences, specializing in healthcare and sustainability. Based in Paris,
London, and Milan, the firm brings together a team of professionals from all
over the world with strong scientific, medical, and business expertise.
Sofinnova Partners is a hands-on company builder across the entire value chain
of life sciences investments, from seed to later-stage. The firm actively
partners with ambitious entrepreneurs as a lead or cornerstone investor to
develop transformative innovations that have the potential to positively
impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply established venture capital
firm in Europe, with 50 years of experience backing over 500 companies and
creating market leaders around the globe. Today, Sofinnova Partners has over
€2.5 billion under management.

For more information, please visit: www.sofinnovapartners.com
(https://pr.report/836lBLkd)

About Bertelsmann Investments

Bertelsmann Investments (BI), bundles Bertelsmann's growth initiatives through
Bertelsmann Next and VC Investment businesses including Bertelsmann Asia
Investments (BAI), Bertelsmann India Investments (BII), and Bertelsmann
Digital Media Investments (BDMI). Bertelsmann's global venture capital arm
currently comprises 300 active investments while Bertelsmann Next is investing
to create transformational businesses in Digital Health, Employability and
other sectors such as App conomy.

For more information, please visit: www.bertelsmann-investments.com
(https://pr.report/uxfisL1J)

SOURCE: deepc

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUWAWROAUOURR